Ticker: PMCB

PharmaCyte Biotech, Inc. (OTCBB: PMCB) Quick read: PharmaCyte is a small-cap biotech focused on its Cell‑in‑a‑Box® CypCaps™ program for pancreatic cancer. The company reduced operating spend, made progress on FDA requests, and completed financing steps after quarter‑end - but booked a large quart...

PharmaCyte Biotech, Inc. (OTCBB: PMCB) has recently published its quarterly report for the period ended January 31, 2025, highlighting key financial insights and operational updates. Key Points: Revenue: $0 for both the three and nine months ended January 31, 2025 and 2024. Total operating expe...